These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37378469)

  • 1. Angiotensin II for the Treatment of Refractory Shock: A Matched Analysis.
    Smith LM; Mentz GB; Engoren MC
    Crit Care Med; 2023 Dec; 51(12):1674-1684. PubMed ID: 37378469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II for the Treatment of Vasodilatory Shock.
    Khanna A; English SW; Wang XS; Ham K; Tumlin J; Szerlip H; Busse LW; Altaweel L; Albertson TE; Mackey C; McCurdy MT; Boldt DW; Chock S; Young PJ; Krell K; Wunderink RG; Ostermann M; Murugan R; Gong MN; Panwar R; Hästbacka J; Favory R; Venkatesh B; Thompson BT; Bellomo R; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Deane AM;
    N Engl J Med; 2017 Aug; 377(5):419-430. PubMed ID: 28528561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use.
    Wieruszewski PM; Wittwer ED; Kashani KB; Brown DR; Butler SO; Clark AM; Cooper CJ; Davison DL; Gajic O; Gunnerson KJ; Tendler R; Mara KC; Barreto EF
    Chest; 2021 Feb; 159(2):596-605. PubMed ID: 32882250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologic Response to Angiotensin II Treatment for Coronavirus Disease 2019-Induced Vasodilatory Shock: A Retrospective Matched Cohort Study.
    Leisman DE; Mastroianni F; Fisler G; Shah S; Hasan Z; Narasimhan M; Taylor MD; Deutschman CS
    Crit Care Explor; 2020 Oct; 2(10):e0230. PubMed ID: 33063034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressor therapy in critically ill patients with shock.
    Russell JA
    Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II in septic shock.
    Jadhav AP; Sadaka FG
    Am J Emerg Med; 2019 Jun; 37(6):1169-1174. PubMed ID: 30935784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initiating angiotensin II at lower vasopressor doses in vasodilatory shock: an exploratory post-hoc analysis of the ATHOS-3 clinical trial.
    Wieruszewski PM; Bellomo R; Busse LW; Ham KR; Zarbock A; Khanna AK; Deane AM; Ostermann M; Wunderink RG; Boldt DW; Kroll S; Greenfeld CR; Hodges T; Chow JH;
    Crit Care; 2023 May; 27(1):175. PubMed ID: 37147690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II for the treatment of distributive shock in the intensive care unit: A US cost-effectiveness analysis.
    Busse LW; Nicholson G; Nordyke RJ; Lee CH; Zeng F; Albertson TE
    Int J Technol Assess Health Care; 2020 Apr; 36(2):145-151. PubMed ID: 32114996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II.
    Tumlin JA; Murugan R; Deane AM; Ostermann M; Busse LW; Ham KR; Kashani K; Szerlip HM; Prowle JR; Bihorac A; Finkel KW; Zarbock A; Forni LG; Lynch SJ; Jensen J; Kroll S; Chawla LS; Tidmarsh GF; Bellomo R;
    Crit Care Med; 2018 Jun; 46(6):949-957. PubMed ID: 29509568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Multicenter Observational Cohort Study of Angiotensin II in Shock.
    Smith SE; Newsome AS; Guo Y; Hecht J; McCurdy MT; Mazzeffi MA; Chow JH; Kethireddy S
    J Intensive Care Med; 2022 Jan; 37(1):75-82. PubMed ID: 33231111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. THE ROLE OF ANGIOTENSIN -2 IN THE PATHOGENESIS OF SEPTIC SHOCK DURING MULTIORGAN DYSFUNCTION SYNDROME (REVIEW).
    Rurua M; Machavariani K; Sanikidze T; Shoshiashvili V; Pachkoria E; Ratiani L
    Georgian Med News; 2022 Feb; (323):157-161. PubMed ID: 35271489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II for the Treatment of High-Output Shock 3 (ATHOS-3): protocol for a phase III, double-blind, randomised controlled trial.
    Chawla LS; Russell JA; Bagshaw SM; Shaw AD; Goldstein SL; Fink MP; Tidmarsh GF
    Crit Care Resusc; 2017 Mar; 19(1):43-49. PubMed ID: 28215131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA Approval of Angiotensin II for the Treatment of Hypotension in Adults with Distributive Shock.
    Senatore F; Jagadeesh G; Rose M; Pillai VC; Hariharan S; Liu Q; McDowell TY; Sapru MK; Southworth MR; Stockbridge N
    Am J Cardiovasc Drugs; 2019 Feb; 19(1):11-20. PubMed ID: 30144016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Retrospective Review of Angiotensin II Use in Adult Patients With Refractory Distributive Shock.
    Wong A; Alkazemi A; Eche IM; Petri CR; Sarge T; Cocchi MN
    J Intensive Care Med; 2020 Dec; 35(12):1490-1496. PubMed ID: 31480886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study.
    Chawla LS; Busse L; Brasha-Mitchell E; Davison D; Honiq J; Alotaibi Z; Seneff MG
    Crit Care; 2014 Oct; 18(5):534. PubMed ID: 25286986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Vasopressors in the Treatment of Vasodilatory Shock: A Systematic Review of Angiotensin II, Selepressin, and Terlipressin.
    Rodriguez R; Cucci M; Kane S; Fernandez E; Benken S
    J Intensive Care Med; 2020 Apr; 35(4):327-337. PubMed ID: 30563433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II in Refractory Septic Shock.
    Antonucci E; Gleeson PJ; Annoni F; Agosta S; Orlando S; Taccone FS; Velissaris D; Scolletta S
    Shock; 2017 May; 47(5):560-566. PubMed ID: 27879559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-Term Organ Dysfunction Is Associated With Long-Term (10-Yr) Mortality of Septic Shock.
    Linder A; Lee T; Fisher J; Singer J; Boyd J; Walley KR; Russell JA
    Crit Care Med; 2016 Aug; 44(8):e728-36. PubMed ID: 27428136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial.
    Annane D; Siami S; Jaber S; Martin C; Elatrous S; Declère AD; Preiser JC; Outin H; Troché G; Charpentier C; Trouillet JL; Kimmoun A; Forceville X; Darmon M; Lesur O; Reignier J; Abroug F; Berger P; Clec'h C; Cousson J; Thibault L; Chevret S;
    JAMA; 2013 Nov; 310(17):1809-17. PubMed ID: 24108515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Angiotensin II in Poisoning-Induced Shock-a Review.
    Chen A; Wong A
    J Med Toxicol; 2022 Apr; 18(2):145-154. PubMed ID: 35258848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.